MSF Responds to FDA's Emergency Use Authorization for Regeneron's COVID-19 Treatment
November 24, 2020
November 24, 2020
NEW YORK, Nov. 24 -- The Doctors Without Borders/Medecins Sans Frontieres issued the following news:
Following US-based Regeneron's United States Food and Drug Administration emergency use authorization for REGN-CoV-2, the international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) is concerned the COVID-19 drug will be priced out of reach or otherwise inaccessible for people all over the world.
To ensure wide access to this me . . .
Following US-based Regeneron's United States Food and Drug Administration emergency use authorization for REGN-CoV-2, the international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) is concerned the COVID-19 drug will be priced out of reach or otherwise inaccessible for people all over the world.
To ensure wide access to this me . . .